Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/91345
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorDepartment of Applied Biology and Chemical Technology-
dc.creatorChung, KPS-
dc.creatorLeung, RWH-
dc.creatorLee, TKW-
dc.date.accessioned2021-11-03T06:52:52Z-
dc.date.available2021-11-03T06:52:52Z-
dc.identifier.urihttp://hdl.handle.net/10397/91345-
dc.language.isoenen_US
dc.publisherMDPI AGen_US
dc.rights© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).en_US
dc.rightsThe following publication Chung, K.P.S.; Leung, R.W.H.; Lee, T.K.W. Hampering Stromal Cells in the Tumor Microenvironment as a Therapeutic Strategy to Destem Cancer Stem Cells. Cancers 2021, 13, 3191 is available at https://doi.org/10.3390/cancers13133191en_US
dc.subjectCanceren_US
dc.subjectCancer stem cellsen_US
dc.subjectImmune cellsen_US
dc.subjectStromal cellsen_US
dc.subjectTumor microenvironmenten_US
dc.titleHampering stromal cells in the tumor microenvironment as a therapeutic strategy to destem cancer stem cellsen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.volume13-
dc.identifier.issue13-
dc.identifier.doi10.3390/cancers13133191-
dcterms.abstractCancer stem cells (CSCs) within the tumor bulk play crucial roles in tumor initiation, recurrence and therapeutic resistance. In addition to intrinsic regulation, a growing body of evidence suggests that the phenotypes of CSCs are also regulated extrinsically by stromal cells in the tumor microenvironment (TME). Here, we discuss the current knowledge of the interplay between stromal cells and cancer cells with a special focus on how stromal cells drive the stemness of cancer cells and immune evasive mechanisms of CSCs. Knowledge gained from the interaction between CSCs and stromal cells will provide a mechanistic basis for the development of novel therapeutic strategies for the treatment of cancers.-
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationCancers, July 2021, v. 13, no. 13, 3191-
dcterms.isPartOfCancers-
dcterms.issued2021-07-
dc.identifier.scopus2-s2.0-85108446469-
dc.identifier.eissn2072-6694-
dc.identifier.artn3191-
dc.description.validate202110 bcvc-
dc.description.oaVersion of Recorden_US
dc.identifier.FolderNumberOA_Scopus/WOSen_US
dc.description.pubStatusPublisheden_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
cancers-13-03191-v2.pdf2.28 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

68
Last Week
2
Last month
Citations as of Apr 21, 2024

Downloads

17
Citations as of Apr 21, 2024

SCOPUSTM   
Citations

7
Citations as of Apr 19, 2024

WEB OF SCIENCETM
Citations

6
Citations as of Apr 25, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.